Showing posts with label drug laws. Show all posts
Showing posts with label drug laws. Show all posts

Friday, April 26, 2019

Joe Biden is the Hillary Clinton of 2020

With now 20 candidates for the Democrat 2020 presidential nomination, the obsession of Democrats ought to be determining which candidate can beat Donald Trump.  All else should pale in comparison  and Democrats should avoid repeating past mistakes.  They need a candidate that can generate excitement and not just among their fraction of the party base that border on cultist for that 
candidate.  Rightly or wrongly, Trump generated excitement among the white supremacists, Christian extremists, and those who wanted to blow up the system.  Excitement is what gets voters to the polls.  A winning candidate also needs to be free from as much baggage as possible that drag the candidate down or turn off critical elements of the voter base.  A lengthy piece in Vox makes the case that if Joe Biden is the 2020 nominee, Democrats will be making the same mistake they made in 2016 by nominating Hillary Clinton.  This go round, there are more candidates to choose from and Democrats need to think long and hard about the most important question: who can beat Trump. A candidate's perfection on every policy issue matters matters far less since, if the candidate cannot win, their policy issues are meaningless. Here are article highlights which too me, are on point:

To a certain kind of Democratic Party establishmentarian, Hillary Clinton lost in 2016 because she was not “likable” enough — a sentiment that may or may not be thinly veiled code for saying that she’s a woman. Their solution in 2020 is good old Joe Biden.
Biden, on the likability frame, is the opposite of Clinton — a back-slapping pol man who enjoys shooting the breeze with reporters. But the reality is Clinton was plenty likable at key moments in her career. Most notably, one of the main reasons the Democratic Party rallied around her so hard in 2014-’15 is that when she was secretary of state, her approval ratings were far higher than Barack Obama’s, and she was an in-demand midterms surrogate even in states where he was toxic.
Biden, meanwhile, was not especially popular as vice president during Obama’s first six years in office and only saw his numbers rise as he appeared to step out of the electoral arena — swapping places with Clinton as the kind of generic Famous Democrat Who Isn’t Running.
What brought Clinton down was public exposure not to her personality — which was sparkling enough to make her the most admired woman in America for 17 years straight before losing the claim to Michelle Obama in 2018 — but extended public scrutiny of every detail of a decades-long career in public life. This, in turn, is the exact same problem Biden will inevitably face as a presidential candidate. Americans like outsiders and fresh faces, not veteran insiders who bear the scars of every political controversy of the past two generations.
Mainstream Democrats like other mainstream Democrats. But what it means to be a mainstream Democrat has changed significantly since Biden entered the Senate 46 years ago. As Democrats gear up to take on Trump, the party’s best shot is to do anything possible to avoid repeating the 2016 experience of defending decades’ worth of twists and turns on various issues from the Iraq War to LGBTQ rights to banking deregulation.
In 2008, Democrats responded to the evident unpopularity and failure of the 2003 war in Iraq in the sensible way — by nominating someone who'd spoken out against the war when he had a chance. . . . yet Democrats chose to saddle themselves with a nominee who’d been a prominent advocate for it.
[A] well-known Iraq War supporter who, unlike Trump, was actually in the Senate at the time was very poorly positioned to argue against him. And by 2020, there’s simply no reason to do that again. Most of the party’s bench consists of people like Sens. Kamala Harris and Amy Klobuchar and Cory Booker, who are young enough not to have participated in the war debate in Congress.
[W]hat’s Biden’s excuse? He was chair of the Senate Foreign Relations Committee at the time — the guy with privileged access to top officials in the American government and around the world. The guy who, though he surely couldn’t have stopped Bush’s folly, certainly could have warned about it.
Foreign policy experience theoretically should be a big Biden advantage over his rivals. But in reality, on one of the only foreign policy controversies voters actually paid attention to or remember, Biden got it wrong in a big way.
[S]ince the founding generation passed away, voters have tended not to want to put veteran politicians in the White House. With only a handful of exceptions, the voters choose to elevate an “outsider” who’s going to “fix the mess in Washington” (or drain the swamp) rather than an inside player who’s mastered the system.
Candidates don’t get credit with voters for mastering Washington. Instead, they end up on defense, defending political decisions that don’t look great in hindsight.
Another major problem for Clinton that emerged over the course of the campaign related to her paid speeches for major banks during the brief window between her service as secretary of state and running for president.
Biden is in no better a position. He spent his whole career in the Senate representing Delaware, a major center of the consumer credit side of the banking industry. He was so close to the local banking giant that he was jokingly referred to as “the senator from MBNA” (which has since been bought by Bank of America).
This made him, among other things, a champion of mostly GOP-supported legislation in 2005 whose aim was to make it more difficult for hard-pressed families to discharge their credit card debt in bankruptcy. . . . Clinton was unusually tight with Wall Street for a Democrat because she represented New York in the Senate, and bankers were her dairy farmers and cheesemakers.
But “I just happen to represent a state whose local business interests are unusually evil” is a terrible public-facing argument (which, of course, is why Clinton didn’t make it). The reality is that very little about Biden’s career is extraordinary. But this, again, is precisely why the voters tend not to choose congressional veterans — people hate business as usual in Washington and want to elect leaders who’ll change the game, not play by the rules.
Biden looks bad in hindsight on a lot of issues.  Marriage equality is in some respects the best example. If you trace the long arc of the Democratic Party’s slow, steady embrace of LGBTQ equality as a cause, then Biden is clearly right there on the journey with everyone else. At a critical moment, he actually led the stampede, as the first Obama administration official to openly embrace marriage equality during the great Obama flip-flop of 2012.
But back in 1996, as a senator, he voted for the viciously discriminatory Defense of Marriage Act. This was, at the time, a totally unremarkable vote — virtually everyone in Congress voted for it.
Biden has, in recent years, been a champion of criminal justice reform just like most Democrats. But in earlier years, when most Democrats were “tough on crime” drug warriors, Biden was a “tough on crime” drug warrior who as a senior member of the Judiciary Committee authored a number of harsh anti-drug laws.
It would be a mistake to see him as some kind of carceral maniac, warmonger, or anti-gay bigot — he was a normal Democrat who had normal Democratic Party positions on a variety of issues over time. But while that extreme normality appeals to party regulars, just as Hillary Clinton appealed to them, the sheer duration of normality means you end up flip-flopping or getting behind the curve in a way that a younger politician wouldn't. And then there are some unique home-state issues.
Had Biden not opted to run, he’d have gone down in history as a senator who was very well-liked by his colleagues and the press, and who served as the popular vice president for one of the most influential presidents of all time. . . . But as a candidate, he’s much too big a fish to be ignored by his rivals, and they’ll have to tear him down.
Some of that will be policy-based, but some of it will probably be personal. Biden has followed Clinton’s footsteps in doing paid speaking gigs while also harboring presidential ambitions — an error that proved costly for her and will likely prove costly for him if it ends up under the microscope. , , , especially because Biden himself can’t seem to decide what he thinks about his handling of the Clarence Thomas confirmation hearings — alternately apologizing for having mishandled things and griping that it’s unfair for Anita Hill to blame him.
Add it all up and you get a negative portrait of Joe Biden — the buckraker who failed to protect a sexual harassment victim and spent the aughts boosting the Iraq War and bank deregulation after fueling mass incarceration and anti-gay discrimination in the 1980s and ’90s.
Times change, and the 2020 presidential campaign will be waged in this moment. And Democrats deserve a nominee who can either plausibly claim to have been prescient on the big changes that have swept progressive politics or is new enough to elective office to simply be of the current moment.

Sunday, August 28, 2016

A Doctor's Case for Marijuana Decriminalization


The City of Norfolk, Virginia recently discussed seeking legislation from the Virginia General Assembly to decriminalized marijuana or at least amend Virginia's draconian marijuana laws. Norfolk has the distinction of the highest number of marijuana arrests which disproportionately impact black male.  It's as if the pattern is part of a Republican plan to arrest, convict and criminalize blacks to keep them off of the voter rolls.  The reality is that the Virginia GOP increasingly survives due solely to gerrymandered districts and all out efforts to disenfranchise minority voters and younger voters. A piece in Salon authored by a doctor looks at the idiocy of the federal government's refusal to change marijuana as a Schedule I drug.  Here are article excerpts:
On August 11th, the Drug Enforcement Administration announced its decision to keep marijuana classified as a Schedule I drug. The federal government has historically referred to this category as the “most dangerous” group of substances, including drugs like heroin and bath salts.
As a resident physician specializing in mental health, I can’t make much sense of this.
Every day, I talk to patients about substance abuse. Whether evaluating patients in clinic, in the emergency department or on inpatient units, my colleagues and I screen patients for substance use. It’s a vital component of any clinical interview, particularly in mental health care, and helps us understand patients’ habits and their risks for medical complications.
During my medical training, I’ve learned which substances to worry about and which ones matter less.
Alcohol is usually the first substance I ask about. Many people have seen drinking go wrong, be it a friend making a bad decision or a family member struggling with alcoholism. But clinicians see the worst of this on the front lines.
Intoxicated patients stream into emergency departments after crashing their cars, inhaling their own vomit or falling into a coma. According to the National Institutes of Health, alcohol-related conditions contributed to more than 1.2 million emergency department visits in 2010. The Centers for Disease Control reports excess alcohol consumption causes roughly 88,000 deaths in the United States each year.
It’s not only alcohol that clinicians worry about. Cocaine can cause heart attacks, kidney failure and complications during pregnancy like placental abruption. Methamphetamine can trigger an assortment of responses, from hyperthermia to violent agitation to cardiogenic shock. Opioids like morphine can plunge patients into respiratory failure and kill them. Intravenous drug use puts patients at risk for hepatitis, endocarditis or even brain abscesses.
But, for most health care providers, marijuana is an afterthought.
We don’t see cannabis overdoses. We don’t order scans for cannabis-related brain abscesses. We don’t treat cannabis-induced heart attacks. In medicine, marijuana use is often seen on par with tobacco or caffeine consumption — something we counsel patients about stopping or limiting, but nothing urgent to treat or immediately life-threatening.
The federal government’s scheduling of marijuana bears little relationship to actual patient care. The notion that marijuana is more dangerous or prone to abuse than alcohol (not scheduled), cocaine (Schedule II), methamphetamine (Schedule II) or prescription opioids (Schedules II, III, and IV) doesn’t reflect what we see in clinical medicine.
Chuck Rosenberg, acting head of the DEA, explained the decision to keep marijuana as a Schedule I drug was based more “on whether marijuana, as determined by the FDA, is a safe and effective medicine.”
Regulations have prevented U.S. researchers from answering this question over the last several decades. As written in a recent editorial in The New York Times, “the government itself has made it impossible to do the kinds of trials and studies that could produce the evidence that would justify changing the drug’s classification.”
Yet, according to a 2015 systematic review, studies from around the world suggest cannabis and cannabinoid therapies may help patients in a number of ways. These include treating chronic pain, muscle spasms, debilitating side effects of chemotherapy like nausea and weight loss from HIV infection. Dozens of U.S. states have listened to such findings in recent years and passed legislation approving the use of medical marijuana.
[O]ur nation’s substance policies should be grounded in the realities of clinical practice.
In hospitals across the country, patients writhe in agony from alcohol withdrawal, turn violent from crystal meth and struggle to breathe after overdosing on prescription opioids. These are the cases that keep health care providers on edge. These are the patients we follow closely. When our pagers go off, we hurry to the bedside, give medications, alert security or even begin resuscitation.
With marijuana? Not so much.